About Intermune
Intermune, a biotechnology company, focuses on developing and commercializing innovative therapies for patients with serious and life-threatening diseases. The company has a strong emphasis on rare diseases, particularly in the areas of pulmonary and fibrotic diseases. Intermune's lead product, Esbriet (pirfenidone), is approved for the treatment of idiopathic pulmonary fibrosis (IPF) and has been recognized for its significant impact on patient outcomes. The company is committed to advancing research and development in the biotechnology sector, aiming to bring new solutions to patients in need. Intermune was acquired by Roche in 2014, which has further enhanced its capabilities and reach in the global market. With a dedicated team and a robust pipeline, Intermune continues to strive for excellence in the biotechnology industry.
Company facts
- Industry
- Biotechnology
- Sub-industries
- Pharmaceuticals, Rare Diseases, Pulmonary Medicine, Fibrosis Treatments, Clinical Research
- Location
- South San Francisco, United States
- Employees
- 201–500
- Founded
- 1998
Products and services
Open Intermune in GlobalDeal Is this your company? Update the details for free
More Biotechnology companies in United States
- Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet medical need. Founded in 1987 and… - Uw School Of Medicine And Public Health
The University of Wisconsin School of Medicine and Public Health (UWSMPH) is a leading institution dedicated to improving health through education, research, and service. It… - Bgi Genomics
BGI Genomics is a subsidiary of the BGI Group, one of the world’s largest genomics enterprises headquartered in Shenzhen, China. The company specializes in next‑generation… - Agilent Technologies
Agilent Technologies, Inc. is a global leader in life sciences, diagnostics, and applied chemical markets. The company provides instruments, software, services, and consumables… - Genentech
Genentech, a member of the Roche Group, is a leading biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious and… - Envigo
Envigo is a global provider of essential products and services for the research and development of new drugs and therapies. The company specializes in the breeding and supply of… - Illumina
Illumina, Inc. is a global leader in genomics, focused on developing innovative technologies for genetic analysis. Founded in 1998 and headquartered in San Diego, California… - Bio-Rad Laboratories
Bio-Rad Laboratories, Inc. is a global leader in life science research and clinical diagnostics. Founded in 1952, the company develops, manufactures, and markets a broad range of… - Csl Behring
CSL Behring is a global biotechnology leader that develops and delivers innovative therapies for people with serious and rare diseases. The company specializes in the development… - Baxalta
Baxalta Incorporated was a global biopharmaceutical company that focused on developing and delivering innovative therapies for people with hemophilia, immune deficiencies, and… - Novonesis
Novonesis is a biotechnology company focused on developing innovative solutions for healthcare challenges. The company specializes in the research and development of biologics… - Celgene
Celgene Corporation, now a subsidiary of Bristol-Myers Squibb, is a biopharmaceutical company that discovers, develops, and commercializes innovative therapies for the treatment…